Literature DB >> 10659480

Non-cirrhotic portal fibrosis in children.

U Poddar1, B R Thapa, P Puri, C S Girish, K Vaiphei, R K Vasishta, K Singh.   

Abstract

BACKGROUND AND OBJECTIVES: Non-cirrhotic portal fibrosis (NCPF) is an infrequent cause of portal hypertension in children. We report 11 children with NCPF, from among 338 with portal hypertension, seen over 6.5 years.
METHODS: The diagnosis was based on patent splenoportal axis on ultrasonography and/or splenoportal venography and liver biopsy showing no evidence of cirrhosis or other diagnosis, in children with portal hypertension. Those with variceal bleed were managed with endoscopic sclerotherapy and/or shunt surgery.
RESULTS: The median age was 11 years (range 5 to 14), and 8 were boys. Presentation was with variceal bleed in 6, lump in left upper abdomen in 5 (though all children had splenomegaly) and esophageal varices on endoscopy. The median spleen enlargement was 8.5 cm; 8 also had hepatomegaly. Hypersplenism was present in 7, and two had developed ascites after bleed. Of 6 children presenting with bleed, variceal obliteration was achieved on sclerotherapy (average 5.6 sessions) in 4 while two underwent shunt surgery for associated hypersplenism. After median follow up of 57.5 months (range 12-78) all are alive and well.
CONCLUSION: NCPF is an uncommon cause of portal hypertension in Indian children. Presentation with variceal bleed is less common than in adults; sclerotherapy is effective.

Entities:  

Mesh:

Year:  2000        PMID: 10659480

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  8 in total

1.  Hepatoportal sclerosis in a child.

Authors:  Nur Arslan; Benal Buyukgebiz; Yesim Ozturk; Samil Hizli; Ozlem Bekem; Ozgül Sagol; Erdener Ozer
Journal:  Eur J Pediatr       Date:  2004-08-17       Impact factor: 3.183

2.  Pediatric non-cirrhotic portal fibrosis: role of endoscopic management in determining long-term outcome.

Authors:  Durga Prasad; Moinak Sen Sarma; Surender Kumar Yachha; Anshu Srivastava; Ujjal Poddar
Journal:  Hepatol Int       Date:  2019-08-29       Impact factor: 6.047

3.  Revisiting extra hepatic portal vein obstruction in children from the north Indian gangetic plain.

Authors:  Sundeep Goyal; V K Dixit; A K Jain; O P Mishra; S K Jena; Jayant Ghosh
Journal:  Indian J Pediatr       Date:  2013-10-10       Impact factor: 1.967

4.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

Review 5.  Management of portal hypertension.

Authors:  S K Yachha; Kamal Chetri; Richa Lal
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

Review 6.  Management of portal hypertension in children.

Authors:  Roberto Gugig; Philip Rosenthal
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

Review 7.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

8.  Etiology and management of hemorrhagic complications of portal hypertension in children.

Authors:  Alejandro Costaguta; Fernando Alvarez
Journal:  Int J Hepatol       Date:  2012-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.